While compelling evidence suggests that AD has a multifactorial aetiology [5], a robust glial-mediated inflammatory response manifests as an early feature of AD pathophysiological mechanisms and plays a pivotal etiopathogenic role [6,7], due to the ability to exacerbate Aβ and Tau pathologies [8,9]. Here, MAPT is linked to Alzheimer disease.